






































1Biochemical Engineering Journal 105 (2016) 481–488
Contents lists available at ScienceDirect
Biochemical  Engineering  Journal
jo ur nal home page: www.elsev ier .com/ locate /be j
egular  article
n-vitro  release  study  of  hydrophobic  drug  using  electrospun
ross-linked  gelatin  nanoﬁbers
nindita  Laha,  Shital  Yadav,  Saptarshi  Majumdar,  Chandra  S.  Sharma ∗
epartment of Chemical Engineering, Indian Institute of Technology Hyderabad, Yeddumailaram, 502205 Telangana, India
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 26 July 2015
eceived in revised form 2 October 2015
ccepted 1 November 2015
vailable online 5 November 2015
a  b  s  t  r  a  c  t
Delivering  hydrophobic  drug  within  hydrophilic  polymer  matrix  as  carrier  is usually  a  challenge.  Here  we
report the  synthesis  of  gelatin  nanoﬁbers  by electrospinning,  followed  by testing  them  as  a  potential  car-
rier for  oral  drug  delivery  system  for a  model  hydrophobic  drug,  piperine.  Electrospun  gelatin  nanoﬁbers
were  crosslinked  by exposing  to saturated  glutaraldehyde  (GTA)  vapor,  to  improve  their  water  resistive






ﬁber  morphology,  but  also  signiﬁcantly  marginalized  any  adverse  effects  associated  with  the use of GTA.
Scanning  electron  microscopy  imaging,  Fourier  transform  infrared  spectroscopy  and  thermogravimetric
analysis  were  done  to  study  nanoﬁber  morphology,  stability  of drug  and  effect  of crosslinking.  The  pH of
release  medium  was  also  varied  as  per the gastrointestinal  tract  for in-vitro  drug  release  study.  Results
illustrate  good  compatibility  of  hydrophobic  drug  in gelatin  nanoﬁbers  with promising  controlled  drug
release  patterns  by  varying  crosslinking  time  and  pH  of  release  medium.icroporous membrane
. Introduction
Controlled drug delivery prevents over-dosing of drug and thus
educes the toxic effects associated with it. Efﬁcacy of adminis-
ered drug can be maintained by keeping the drug concentration
n the body within its therapeutic window [1]. Due to the con-
enience of delivery and better patient compliance, oral route is
ostly preferred [2]. To administer the drug release in the oral
oute, drug molecule is generally encapsulated in excipients, which
rotects the bioactive molecule from enzymatic degradation in gas-
rointestinal (GI) tract. These excipients can be in various physical
orms such as micro/nanoparticles [3–5], hydrogels [6,7], thin ﬁlms
8,9], micelle [10,11], micro/nanogels [12,13] etc.  However over the
ast decade, nanoﬁbers have been demonstrated as potential drug
elivery systems due to their large surface area to volume ratio and
ontrollable porosity, thereby resulting high drug loading capacity
14]. As majority of the drugs are highly hydrophobic with poor
ater solubility, nanoﬁbers due to their large speciﬁc surface areaacilitates their enhanced oral absorption [15]. Among the several
echniques to fabricate nanoﬁbers such as phase separation, self-
ssembly, electrospinning etc.; electrospinning is mostly preferred
ue to its versatility in terms of use of large number of polymers,
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ease of control on ﬁber size with well-deﬁned morphology and
better scalability [14–17].
Gelatin is one of the most commonly used FDA approved
biopolymer, as an excipient because of its biocompatibility,
biodegradability, muco-adhesiveness and easy availability. It has
generally been used as drug carrier in different forms such as
hydrogels, microspheres, nanoparticles etc.  [18]. As gelatin is con-
sidered to be poor in ﬁber processing, biomedical usage of gelatin
nanoﬁbers in tissue engineering, scaffold/bone repair, wound heal-
ing and drug delivery are based on composite ﬁbers [19–23].
Although in recent times, only gelatin based electrospun nanoﬁbers
are also synthesized using different solvent systems, however there
are very few studies available on only gelatin nanoﬁbers used
as a drug carrier [24–27]. Further to the best of our knowledge,
there is no report on controlled release of hydrophobic drug using
electrospun gelatin nanoﬁber except a recent demonstration of
slow release of nystatin, an anti-fungal reagent [24]. More impor-
tantly, there is a need of systematic effort in literature to study the
release of hydrophobic drug and correlate it with physiochemical
conditions as well as structural properties of pure gelatin based
electrospun ﬁber mat.
Electrospun gelatin nanoﬁbers are water soluble, which limits
their applications and long term use [28]. The crosslinking agent
like formaldehyde [29], genipin [30], glutaraldehyde (GTA) etc.  [31]
have been reported in the literature, to modify gelatin via its amino,
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ecause of its efﬁciency in stabilizing collagenous materials [28]
nd reducing biodegradation of such materials.
The objective of present work is to study the stability and release
f hydrophobic drug from electrospun hydrophilic carrier. Piper-
ne is selected as model hydrophobic drug. Piperine (1-piperoyl
iperidine) is commonly known for its bio-enhancing effect on
ther co-administered drug [32]. It has been reported that piper-
ne increases the bio-availability of curcumin, an anti-cancerous
rug by 2000% in humans [33]. It also shows anti-depression, anti-
nﬂammatory, anti-bacterial properties [32].
Gelatin nanoﬁbers were prepared using electrospinning with
s well as without piperine and cross-linked using saturated GTA
apor. Further, in-vitro release studies were performed at vary-
ng pH conditions matching human GI tract environment. Thus,
e have tried to co-relate the morphology, in-vitro biodegradation
tudy, stability of hydrophobic drug and effect of crosslinking with
n-vitro release study of hydrophobic drug through hydrophilic
elatin nanoﬁber. This study attempts to draw a much needed
ttention toward exploring full potential of electrospun nanoﬁbers
s a drug delivery system, particularly for hydrophobic drugs.
. Materials and methods
.1. Materials
Gelatin (Type A, 175 bloom), Piperine (98%), Hydrochloric acid
ACS, 36.5–38.0%), Gluteraldehyde (25% v/v aqueous solution),
cetic acid (glacial, ACS, 99.7+%), Sodium hydroxide pallets (98%),
hosphate buffer saline (pH 7.4) were purchased from Alfa Aesar,
ndia. Deionized water (DI) (Model: Milli Q, Millipore India, resis-
ivity 18.1 )  was used throughout the experiments.
.2. Preparation of nanoﬁbrous membranes
.2.1. Preparation of electrospinning solution
Gelatin (Type A) was dissolved in acetic acid solution (20% v/v in
istilled water) at 20% (w/v). The solution was stirred on a magnetic
tirrer for 3 h at room temperature to get clear and homogenous
olution, which was used to prepare gelatin nanoﬁbers (GNF). In
he prepared gelatin solution, piperine (2 mg/ml) was  added and
tirred for 2 h, to prepare piperine loaded gelatin nanoﬁbers (G-P
F).
.2.2. Electrospinning
Electrospun nanoﬁbers were prepared using electrospinning set
p purchased from E-Spin Nanotech Pvt. Ltd, India. The spinning
olution was transferred to 3 ml  plastic syringe with needle diam-
ter of 21 gauge, by carefully avoiding air bubbles. The syringe was
laced horizontally on the syringe pump. The ﬂow rate of the feed
olutions were controlled by syringe pump to make sure homo-
eneous ﬂow (5 l/min) though out the deposition. The electric
otential of 12 kV was applied between tip and collector by the high
oltage power supply maintained at a distance of 10 cm.  The metal
ollector was covered by aluminum foil which was  used as a sub-
trate for deposition. Electrospinning process was carried out in the
nclosed electrospinning apparatus at room temperature (27 ◦C)
nd 50% relative humidity.
.2.3. Crosslinking electrospun membranes
Electrospun GNF and G-P NF membranes dissolve within few
econds in water, therefore, crosslinking was done by exposing it
o saturated vapor of GTA (25% v/v aqueous solution). Both GNF
nd G-P NF, with and without substrate (i.e., aluminum foil), were
ut into 2 × 2 cm2 sample sizes. These samples were placed inside
he closed glass desiccator having 20 ml  of GTA solution. Exposure
o GTA vapor was done at room temperature for different timeg Journal 105 (2016) 481–488
intervals i.e., 2, 4, 6, 8 and 10 min  respectively. These cross linked
samples now onwards are referred as GNF CX and G-P NF CX where




The morphology of the GNF and G-P NF samples, with and
without crosslinking were examined by Field Emission Scanning
Electron Microscopy (FESEM) (Model: SUPRA 40, Zeiss, Germany)
at 10 kV with working distance 7.0 mm.  The samples were sputter-
coated with gold, to reduce charging effect.
2.3.2. Speciﬁc Surface Area (SSA) measurement
The Brunauer–Emmett–Teller (BET) surface area of GNF and GNF
C6 was determined by N2 physisorption using Micromeritics ASAP
2020 physisorption analyzer (USA). The sample mass was about
100 mg.  All samples were degassed at room temperature for 6 h in
nitrogen. The SSAs were determined by a multi-point BET measure-
ment with nitrogen as the adsorbate.
2.3.3. Porosity measurements
To measure the porosity of nanoﬁber mat, samples were cut in
equal pieces (1 × 1 cm2) and weighted. The thickness of the electro-
spun mat  at minimum three different places was measured using
digital micrometer (Mitutoyo, Japan). The apparent volume (Va)
was determined using the average thickness of the mat. The vol-
ume  of the mat  (Vg) was determined on the basis of gelatin density
(1.41 g cm−3) and piperine (1.19 g cm−3) density and their mass
percentage compositions adapted from [24]. Finally the porosity










Electrospun non-crosslinked and crosslinked GNF and G-P NF
were characterized by using Fourier Transform Infrared (FTIR)
spectrometer (Model: Alpha-P, Bruker Corporation, USA). IR spec-
troscopy is mainly performed using the attenuated total reﬂection
(ATR) method without any pre-treatment of the nanofabric sam-
ples. Spectra were obtained with 16 scans per sample at a resolution
of 4 cm−1 between 4000 and 500 cm−1. All the spectra were fur-
ther processed using OPUS software which was  installed in the
instrument system and plotted using Origin pro8.
2.3.5. Thermogravimetric analysis
Thermogravimetric analysis (TGA) of GNF, GNF C6, G-P NF and
G-P NF C6 were carried out using platinum pan in helium atmo-
sphere (Model: Pyris 1, PerkinElmer Inc., USA). Sample weight
varies from 5 to 10 mg. Samples were heated from room tempera-
ture to 600 ◦C at a heating rate of 10 ◦C/min.
2.4. In-vitro biodegradation study
In accordance with oral delivery systems, pH of release medium
was varied as per the gastrointestinal tract (GI) in human body.
The pH of stomach is pH 1.5–4 due to gastric acids. The pH of
small intestine (duodenum) varies from pH 6–8, where maximum
absorption of nutrients takes place. Therefore, pH 1.2, 6, 7.4 and
8 are selected for further in-vitro biodegradation as well release
study. In-vitro biodegradation study helps in determining the sta-
bility of the cross-linked electrospun mat  in different physiological
pH solutions. For this study, 5 × 5 cm2 of electrospun GNF and G-P
NF samples, cross-linked over different time intervals, were kept

















































Fig. 1. Digital images representing, (a) non crosslinked GNF  (b) shrinked GNF  C6
and  (d) GNF C6 in DI water.
Table 1
Summary of in-vitro biodegradation study for GNF and G-P NF crosslinked over
different time interval, in dissolution medium of different pH.
pH of dissolutionmedium Time of crosslinking with GTA (25% v/v) vapor
GNF G-P NF
0 2 4 6 8 10 0 2 4 6 8 10
1.2 – + + + * * – + + * * *
6  – + * * * * – + * * * *
7.4  – * * * * * – + * * * *A. Laha et al. / Biochemical Eng
n 25 ml  solutions of pH 1.2, 6, 7.4 and 8 respectively in mechan-
cal shaker (Model: RIS-24 plus, Remi India) for 24 h, at 37 ◦C and
50 RPM.
.5. In-vitro release study
The release of drug i.e., piperine from electrospun nanoﬁber
ats was measured by placing 5 × 5 cm2 of drug loaded ﬁber mat  in
0 ml  of release medium at different physiological pH levels (1.2, 6,
.4 and 8). The temperature and stirring of the system were main-
ained at 37 ◦C and at 50 RPM, respectively. An aliquot sample was
ithdrawn, at ﬁxed time intervals and same amount of fresh solu-
ion was added back to the release medium to maintain the sink
ondition. The samples were centrifuged (Model: CF-10, DAIHAN
iseSpin, Korea) for 2 min  at 1300 RPM and analyzed using an UV
pectrophotometer (Model: Lambda 35, PerkinElmer Inc., USA) at
42 nm as max for piperine. The results were presented in terms
f cumulative release as a function of time:






here Ct is the amount of piperine released at time t and C∞ refers
o total amount of drug loaded in 5 × 5 cm2 sample.
.6. Controlled drug release mechanism and mathematical
odeling
To understand the drug release kinetics and the mechanism, the
btained data from in-vitro study was analysed using mathemati-
al model. The most common equation to describe polymeric drug






here Mt and M∞ = absolute cumulative amount of drug released
n time t and ﬁnal respectively, KH is a dissolution constant [34].
.7. Statistical analysis
Data was analyzed with t-test to compare the difference
etween two treatment means. The null hypothesis is that the
eans of the measurement variable are equal for the two  treat-
ents. Results were recognized as statistically signiﬁcant at the
evel of p < 0.05. The observations are presented as mean ± standard
eviation (SD) of three independent experiments to conﬁrm repro-
ucibility of the ﬁndings. All the plots were analyzed using Origin
ro 8 software.
. Results and discussion
.1. In-vitro biodegradation of the mat
Fig. 1 summarizes the effect of crosslinking on GNF. Fig. 1a
epresents the non-crosslinked GNF membrane with aluminum
oil. Lysine is one of the amino acids present in gelatin, which
s responsible for crosslinking with aldehyde group of GTA [31].
fter crosslinking, sample shrinks as shown in Fig. 1b. Therefore,
embranes are not peeled from aluminum foil in order to avoid
xcessive shrinkage of membrane on cross linking. Fig. 1c shows
he stability of crosslinked gelatin nanoﬁber membrane in aque-
us medium even after keeping immersed. In-vitro biodegradation
tudy was then done with the aim to check the stability of samples
p to 24 h. GNF and G-P NF membrane with different crosslinking
ime are summarized in Table 1. Samples with different crosslink-
ng time (non-cross-linked i.e., 0 min  and cross-linked for 2, 4, 6, 8
nd 10 min) were undergone the degradation at different pH (1.2,8  – * * * * * – * * * * *
Where, ‘–’ means completely degraded, ‘*’ means not degraded and ‘+’ refers to
partial degradation in the dissolution medium after soaking for 24 h.
6, 7.4 and 8) solutions. Results of in-vitro biodegradation study for
electrospun samples cross-linked for 6 min  or above were found to
be stable even after 24 h in all pH conditions. So, 6 min crosslink-
ing time was  selected for further analysis with a better comparison
with 4 and 8 min  crosslinked samples.
These results are quite signiﬁcant while compared to previous
reports on crosslinking of gelatin nanoﬁbers [25,26,28]. Although
GTA is very effective in cross linking gelatin and therefore widely
used, however its prolonged exposure up to 24 h as reported in
literature [26,28] may  have adverse cytotoxic effects. Here in this
work, we  expose only for 6 min  to saturated GTA vapor for cross-
linking to achieve the desired stability of the fabric.
3.2. Surface morphology
The surface morphology of electrospun GNF and G-P NF mem-
brane with and without crosslinking are represented in Fig. 2. SEM
micrographs shows continuous, long nanoﬁbers with ﬁber diame-
ter in the range of 50–200 nm for both GNF and G-P NF as shown
in Fig. 2a and c respectively.
Due to the hydrophilic nature of gelatin, it allows the water
molecules along with GTA molecules from the saturated vapor,
leading to changes in morphology on crosslinking even for only
6 min. It can be observed that the ﬁbers fuse with one another at
contact points (Fig. 2b), as a result of the partial dissolution of the
ﬁber segments when they come in contact with moisture rich GTA
vapor [28,35]. However, in case of G-P NF, presence of hydropho-
bic piperine discourages the interaction of water molecules in GTA
vapor with ﬁbers. It leads to relatively less fusing and minimal effect
on ﬁber morphology at the point of contact of ﬁbers (Fig. 2d).
3.3. Speciﬁc surface area and porosityBET surface area of electrospun GNF was  found to be
23.4 ± 1.2 m2/g. On exposing for 6 min  with saturated GTA
vapor, the BET surface area decreased to 18.2 ± 1.8 m2/g.
A similar change in total pore volume was  also observed
484 A. Laha et al. / Biochemical Engineering Journal 105 (2016) 481–488




































oFig. 2. FESEM images of electrospun (a) GNF;
0.063 ± 0.001 and 0.05 ± 0.001 cm3/g for electrospun GNF and GNF
6 respectively). However average pore diameter as measured by
arrett–Joyner–Halenda (BJH) method remains almost unchanged
o 10.8 ± 0.9 and 10.9 ± 0.6 nm for electrospun GNF and GNF C6 ﬁber
amples respectively. These results are also reﬂected in the porosity
easurements. For GNF, porosity was measured to be 89.9 ± 0.3%
hich reduced to 83.3 ± 1.0% after 6 min  cross linking. This decrease
n surface area, porosity and total pore volume can be explained due
o fusion of ﬁbers in contact with water molecules present along
ith GTA vapor, as illustrated in Fig. 2. Similarly as expected for G-P
F, reduction in porosity after crosslinking (6 min) was signiﬁcantly
ess (90.2 ± 0.8–87.9 ± 0.8%) which was also evident from FESEM
mages in which ﬁber morphology remain almost intact even after
rosslinking. Therefore, the electrospun G-P NF membrane fabri-
ated and used as carrier has sufﬁciently large surface area, even
fter crosslinking with GTA vapor.
.4. Thermal properties
TGA analysis of electrospun GNF, GNF C6, G-P NF and G-P NF C6
abric are shown in Fig. 3. Initial weight loss up to 100 ◦C is found
o be 6.6, 7.5, 7.5 and 7.7% for GNF, GNF C6, G-P NF and G-P NF
6 respectively, due to the elimination of absorbed and bounded
ater molecules in the membrane. In case of pure gelatin ﬁbers,
eight loss after cross linking increases from 6.6 to 7.5% as com-
ared to non-crosslinked samples. Similar observation is made for
iperine loaded gelatin nanoﬁbers before and after crosslinking
7.5–7.7%). This increase may  be due to more adsorption of water
olecules present along with GTA molecules while crosslinking
ith saturated vapor. However more interestingly, we  observe that
or drug loaded nanoﬁber samples, this increase in weight loss after
rosslinking was less (0.2%) as compared to pure gelatin nanoﬁbers
0.9%). As discussed earlier in Section 3.2, this is due to hydrophobic
ature of drug (piperine) which restricts the adsorption of water
olecules during crosslinking which is also evident from FESEM
mages of G-P NF C6 samples (Fig. 2d) showing intact ﬁber mor-
hology even after crosslinking. Further second stage of weight loss
s observed from 250 to 450 ◦C corresponds to thermal degradation
f gelatin due to the breakage of protein chain. For GNF and G-P NF,Fig. 3. Thermogram of GNF, GNF C6, G-P NF, G-P NF C6 samples.
this weight loss was found to be 56.3 and 55.5% respectively that
was reduced to 43.9 and 46.3% for GNF C6 and G-P NF C6 sample
respectively. Thus we observe that crosslinking with GTA vapor for
6 min  (GNF C6 and G-P NF C6), increased the thermal stability of
the fabric which was  further improved by adding the hydrophobic
drug (piperine).
3.5. Drug–polymer interaction: FTIR analysis
To know the chemical composition, effects of crosslinking
and the interactions between the drug and polymer matrix FTIR
analysis were attempted. The absorption bands at 3273.10 cm−1
(N H stretch), 1631.66 cm−1 (amide I, C O and C N stretch),
1536.31 cm−1 (amide II, N H bend and C H stretch) and
1237.88 cm−1 (amide III) are the characteristic bands of GNF
(Fig. 4a) [35]. On crosslinking, aldehyde group ( CHO) of GTA reacts
with the amino group of the lysine which is present in gelatin and
amino ( NH2) groups interact with the carbonyl groups of GTA  to
form new covalent ( C N ) bonds [31]. During crosslinking, ﬁrst
A. Laha et al. / Biochemical Engineering Journal 105 (2016) 481–488 485










































List of drug release co-efﬁcient as ﬁtted in Higuchi Model.
Release model Samples (6 min)
pH 1.2 pH 6 pH 7.4 pH 8ig. 4. FTIR spectra of (a) GNF and GNF C6 showing the effect of crosslinking; (b) 
piperine) in electrospun gelatin ﬁber matrix.
mide I (C O and C N stretching) peak shifts from 1605.30 cm−1 to
631.87 cm−1 indicating its interaction during crosslinking. Similar
rends are also observed in amide II and III peaks of gelatin, which
onﬁrm the hydrogen bonding with aldehyde groups of GTA.
Fig. 4b represents the effect of crosslinking in presence of
iperine. The absorption bands at 2920.71 cm−1 (aliphatic C H
tretching), 1567.03 cm−1 (aromatic stretching of C C, benzene
ing) and 1231.62 cm−1 (asymmetrical stretching of C O C) are
he characteristic bands of piperine. The presence of absorption
eak due to C H stretching around 2909.59 cm−1 (G-P NF) and
919.71 cm−1 (G-P NF C6) are attributed to the presence of piper-
ne in the matrix. Similar peaks are observed due to asymmetric
tretching of C O C in G-P NF (1220.35 cm−1) and G-P NF C6
1229.34 cm−1) samples respectively. This conﬁrms the success-
ully loading piperine in the nanoﬁbers. Absence of any new peak
urther and no signiﬁcant shift in the peak position in piperine
oaded nanoﬁbers also shows the stability of the drug in both
on-crosslinked and crosslinked samples conﬁrming no physical
r chemical interaction of hydrophobic drug with hydrophilic poly-
er  matrix.
.6. In-vitro drug release study
The release of drug from a polymer matrix is modulated by diffu-
ion of drug and/or degradation of the polymer matrix. Insufﬁcient
hysical and chemical interactions (as evident in the FTIR study)
etween the hydrophobic drug molecules and the hydrophilic poly-
er  matrix led to sudden release of drug molecules within few
ours from the surface. As the crosslinked G-P NF membrane swells,
ue to presence of water molecules, the osmotic pressure provides
he driving force for release of drug in the release medium. There-
ore, after 2 h, there is sustained release of drug as drug diffuses to
he release medium through the carrier gradually.
.6.1. Effect of pH value of release medium
Studying and controlling the drug release at different pH is an
mportant consideration for designing a vehicle for oral route. As
rug molecules need to follow the GI tract and should be absorbed
n small intestine, we need to examine release proﬁle from harsh
cidic conditions to slight basic environment. In this work, in-vitro
rug release studies were performed in different pH conditions as
er the human GI tract environment i.e., pH 1.2 (stomach), pH 6
duodenum), pH 7.4 (small intestine) and pH 8 (large intestine) as
hown in Fig. 5.
For crosslinking time of 4 min  (G-P NF C4), piperine release per-
entage was 95.7 ± 3.6, 90.5 ± 3.1, 82.8 ± 6.0, 77.8 ± 3.0% (Fig. 5a)Higuchi
model
KH 0.036 0.037 0.045 0.0588
R2 0.9776 0.9846 0.9949 0.9892
while for crosslinking time of 6 min  (G-P NF C6), drug release per-
centage was  signiﬁcantly decrease 87.7 ± 2.1, 85.6 ± 2.9, 77.6 ± 5.8
and 72.6 ± 3.4% for pH values 8, 7.4, 6 and 1.2 respectively (Fig. 5b).
We observe that the total amount of drug release is less in the
solution with pH 1.2, compared to higher pH, irrespective of
crosslinking time. This may  be due to protonation of hydrophilic
groups of the polymer matrix in acidic pH, which discourages for-
mation of H-bonds with water molecules resulting in less swelling
of the membrane [36]. If the matrix is not swelling much, drug
molecules will not get enough osmotic pressure, helping in reduc-
ing drug release amount. However in alkaline pH, hydrophilic
groups form more H-bonds with release medium which invites
more water molecules inside the carrier leading to better swelling
and more drug release in the dissolution medium. Similarly, with
compare to G-P NF C6 and G-P NF C8 (Fig. 5c), after 24 h, piperine
release was  decreased signiﬁcantly 72.7 ± 8.1, 65.5 ± 4.6, 62.6 ± 0.4
and 58.6 ± 3.6% for pH values 8, 7.4, 6 and 1.2 respectively, demon-
strating the above explanation.
3.6.2. Effect of crosslinking time
With increasing the crosslinking time from 6 to 8 min, the large
amount of drug release in pH 1.2 can be controlled. Our main objec-
tive is to release maximum drug in higher pH (7.4, 8) i.e., pH of small
intestine, where drug will be absorbed. In release medium of pH 1.2,
the amount of drug release, within 2 h, for G-P NF C4, G-P NF C6 and
G-P NF C8 are approximately 48.5 ± 2.9, 45.5 ± 2.7 and 30.5 ± 2.6%
of total drug respectively (Fig. 6a). Further, the drug release amount
decreases signiﬁcantly from 72.6 ± 3.4% in G-P NF C6 to 58.5 ± 3.6%
in G-P NF C8, after 24 h release in pH 1.2. Therefore, increase in
crosslinking time decreased the release percentage.
Similar control over the release percentage was obtained for
pH 6, 7.4 and 8 for both initial fast release and prolonged sus-
tained release as shown in Fig. 6b–d. Therefore, manipulating the
crosslinking exposure time from 4 to 8 min, we can engineer the
inter-ﬁbrous porosity, which may  result in sustained release of drug
molecules. Also, from release study we  can conclude that, the vehi-
cle (G-P NF C6) is capable of protecting the drug from the harsh
486 A. Laha et al. / Biochemical Engineering Journal 105 (2016) 481–488












aig. 6. Cumulative in-vitro release patterns of piperine for different crosslinking tim
edium  (signiﬁcance value, p < 0.05).
ondition (pH 1.2) of GI tract and is able to release in the absorption
ite, i.e., small intestine, in a sustained manner.
.6.3. Drug release mechanism:
To understand the release mechanism, the in-vitro release data
as analyzed using the classical Higuchi model and respective
iguchi dissolution constants are presented in Table 2. It is a very
lear indication that, diffusional force is playing the major role for
rug delivery. The decrease in KH values were found for all the cases
hich indicates the increase in diffusional barrier. The probable
easons behind the increased diffusional barrier are the diffused
nd packed ﬁber structure which also reduces drug molecule pen- NF C4, G-P NF C6, G-P NF C8) in (a) pH 1.2; (b) pH 6; (c) pH 7.4; and (d) pH 8 release
etrability through the matrix. With increase of crosslinking time, KH
value has decreased. Porosity, morphological images, release study
data also support these observations. The KH value can be a good
indicator for required drug release proﬁle.
As compared to the previous reports where electrospun gelatin
nanoﬁbers are used for drug delivery [24–27], these results suggest
to provide a tighter control over sustained drug release and that too
at different pH of the release media, as summarized in Table 3.
As mentioned earlier, there is only one report on release of
hydrophobic drug from electrospun gelatin nanoﬁbers. Even in that
report [24], release study was done only at a given pH 7.4. Addi-
tionally, either there was an initial burst release (75% release in
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Table  3
A comparison of the present work with drug release proﬁle from electrospun gelatin nanoﬁbers reported in literature.
S. No Crosslinker/time of cross linking Drug/nature Solvent Remarks
1 Polyethyleneglycol-diacrylate/30 min  Nystatin/hydrophobic HFP (i) Drug release study only at pH 7.4
(ii) Fiber diameter: few microns
(iii) Initial burst release (75% in 24 h)
2  Proanthocyanidin, GTA/45 min  MAP/ hydrophilic Formic acid (i) PVA is added in gelatin for
producing nanoﬁbers
(ii) Prolonged exposure to GTA
(iii) Initial burst release (65% in 1 h)
3  GTA/24 h Heparin/ hydrophilic Aqueous acetic acid (i) Prolonged exposure to GTA

















































[4  NHS, EDC/24 h Cefradine/hydro
rst 24 h) or very slow release (35% release in ﬁve days with 22%
elease in ﬁrst 24 h). Further as we see in Table 3, all previous reports
ased on only electrospun gelatin nanoﬁbers focus either to deliver
he hydrophilic drug [25–27] or cross linking is done for prolonged
ime (up to 24 h) [24–27] or there is a unwanted signature of ini-
ial burst release [24,25,27]. Clearly this work addresses most of
hese challenges as conﬁrmed by in-vitro drug release studies dis-
ussed above and suggests that controlled crosslinking plays a very
mportant role in porosity of the matrix with minimal effect on
ber morphology. This in turn essentially helps to get stable, sus-
ained and control release of hydrophobic drug with highly porous
lectrospun gelatin nanoﬁber matrix as a delivery vehicle.
. Conclusions
Electrospun gelatin nanoﬁbers were fabricated and exposed to
aturated GTA (25% v/v) vapor for crosslinking. Interestingly, only
 min  exposure was sufﬁcient to control the degradation. Besides
ncreasing water resistivity, crosslinking also improved the thermal
tability of membrane. These electrospun gelatin ﬁbers were then
uccessfully demonstrated as a carrier for a model hydrophobic
rug i.e., piperine. This system have the potential in drug deliv-
ry system due to following observations: (i) piperine was  found
o be stable in hydrophilic electrospun gelatin nanoﬁber carrier;
ii) from in-vitro release study, piperine was effectively delivered
ver prolonged duration of release; (iii) piperine release rate can
e modulated by pH of the release medium at the site of release
nd the degree of cross-linking of the carrier.
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